Downregulation of PGC-1α in the hippocampus of T2DM may result from dipeptidyl peptidase-4 binding to protease-activated receptor 2 and triggering glycogen synthase kinase-3β (GSK3β) activation [133]. The gene discussed is PPARGC1A; the disease is type 2 diabetes mellitus.